生命科学资讯
生物技术与制药领域的最新动态
United Therapeutics’ phase 3 win tees up filing to challenge J&J in cardiac condition
UniQure shares crash 40% as FDA rejects early approval path for Huntington's gene therapy
FDA fully releases clinical hold on Intellia CRISPR gene therapy trials
赛默飞世尔科技推出新型显色培养基，助力快速检测念珠菌感染*，包括耐药性耳念珠菌——BioSpace
Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris - BioSpace
Roche gets third pivotal win with MS drug, but liver signal could be a problem
FDA lifts hold on second Intellia Phase 3 gene editing trial
Stifel raises 10X Genomics stock price target on product adoption - Investing.com
Med-tech outlook 2026: exits, financings, headwinds
Biggest gainers and losers for Feb. 23-27, 2026
Candid to go public via reverse merger with Rallybio
10x Genomics (NASDAQ:TXG) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Bavarian Nordic CEO Paul Chaplin exits, months after failed $3B takeover
Atrium Tx launches with Avidity's RNA ticker and cardio assets
Safety concerns spur Aardvark to halt key Prader-Willi drug trial
Big Pharma’s next entrant could come from China
Shionogi synthesizes new compounds for malaria
UniQure says FDA prefers randomized trial for Huntington's treatment
安捷伦科技公司(A)股票分析：探讨医疗保健板块34.15%上涨潜力 - DirectorsTalk专访
Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 34.15% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Thermo Fisher Scientific Inc. $TMO股票持仓获Fisher资产管理公司增持 - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Increased by Fisher Asset Management LLC - MarketBeat